Google Übersetzer
Design Therapeutics, Inc.
About
10.73USD+0.03 +0.28%
Closed • Updated at 18:34 GMT+00:00Market Cap$670.16M
Volume1.48M
Beta0.17
RSI36.38
Design Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 17 2026
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
Apr 28 2026
Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
Mar 9 2026
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
Nov 26 2025
Design Therapeutics to Participate in Upcoming Investor Conferences
Recent Videos
Via News: AI-Designed Antibody BD200 Outperfo | Oil Hits $100 as US Threatens Hormu
Apr 19, 2026
AI Designs Gut Cures!
Mar 04, 2026
Eyecelerator @ Park City 2025 | Anterior Segment Showcase: Design Therapeutics, Inc
Jan 09, 2026
PRICE BREAKOUT : DSGN STOCK ANALYSIS | DESIGN THERAPEUTICS STOCK
Dec 15, 2025